NCCN 2017 Oncology Fellows Program: New Horizons in Quality Cancer Care™

Orlando, FL US
March 26, 2017

The purpose of this well-regarded program is to educate future oncology practitioners about the application of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and other evidence-based treatment principles in the management of significant cancer types and supportive care issues.

Target Audience

This educational program is designed to meet the educational needs of second- and third-year medical, surgical, and radiation oncology fellows.

Learning Objectives

Following this program, participants should be able to:

Multidisciplinary Management of Esophageal and Esophagogastric Junction (EGJ) Cancers
•    Develop an individualized treatment plan incorporating combined modality therapy for patients with locoregional esophageal and EGJ cancers based on the histology, tumor stage and anatomic location
•    Identify patients with advanced or metastatic esophageal and EGJ cancers most likely to benefit from targeted therapies

Recognition and Management of Treatment-Induced Cardiac Toxicity in Cancer Survivors
•    Recognize risk factors for the development of heart failure in cancer survivors
•    Summarize the recommendations regarding screening for and treatment of anthracycline-induced cardiotoxicity in the NCCN Guidelines for Survivorship

Things A Oncology Fellow Needs to Know (That Won’t Be Taught in Fellowship)
•    Interpret the major legislation that has shifted the clinical care landscape from one that is pay for quantity to one that is pay for value
•    Describe the different care models and federal initiatives relevant to improving cancer care delivery

The Role of Imaging for Staging and Treatment Planning in Gynecologic Malignancies
•    Outline the role of imaging in the evaluation, treatment, and surveillance of gynecologic malignancies
•    Discuss appropriate applications of various imaging modalities in this patient population

Multidisciplinary Management of Head and Neck Cancer
•    Evaluate the need for a multidisciplinary team in caring for patients with head and neck cancer
•    Assess the supportive care needs of patients undergoing treatment for head and neck cancer, such as nutrition and dental evaluation and management

Combination Therapies for Advanced Melanoma
•    For first-line treatment of advanced melanoma, list factors to consider when determining whether a patient should receive (1) a checkpoint immunotherapy versus a BRAF-targeted therapy and (2) a monotherapy versus a combination therapy
•    For second-line or subsequent therapy in patients with advanced melanoma, list appropriate treatment options based on a patient’s response to prior therapy

Additional information

This activity is supported by educational grants from: AstraZeneca; Pfizer; Prometheus Laboratories Inc.; supported by educational funding provided by Amgen; supported by an independent medical education grant from Bristol-Myers Squibb; and supported by an independent educational grant from TESARO. 

Course summary
Course opens: 
Course expires: 
Event starts: 
03/26/2017 - 7:30am EDT
Event ends: 
03/26/2017 - 11:30am EDT
The Rosen Shingle Creek
9939 Universal Boulevard
Orlando, FL 32819
United States

All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.


Please login or register to take this course.